Stage III or IV chronic traumatic encephalopathy (CTE) pathology was associated with increased odds of dementia in a large autopsy study. The study assessed brain donors with CTE pathology and no ...
The largest study of its kind from the Boston University CTE Center reveals that chronic traumatic encephalopathy (CTE) should be recognized as a new cause of dementia. The research, published online ...
Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...
Forget reducing wrinkles and fighting hair loss. Chronic traumatic encephalopathy (CTE) is often observed in football players due to tackles and falls. Getty Images While it hasn’t been put to the ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...
CHICAGO (WLS) -- Football players are among the professional athletes at highest risk for developing a neurodegenerative disease known as CTE. Currently, it can only be identified during an autopsy, ...
Parents at nine Houston ISD high schools beginning today and throughout the week will hear why HISD believes it’s going to be better for their kids to be bused to the Barbara Jordan Career Center than ...
Students are increasingly interested in focusing on digital technology, information technology, artificial intelligence, and cybersecurity in their career and technical education courses, according to ...
On a 40-degree December day in the Central Valley, two dozen high school students in firefighter gear steady themselves before carrying and climbing a 24-foot, 100-pound ladder. They balance the ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. Before market open, ...